scispace - formally typeset
E

Eric J. Topol

Researcher at Scripps Health

Publications -  1406
Citations -  162373

Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.

Papers
More filters
Journal ArticleDOI

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study

TL;DR: The statistically non-significant trend toward improved outcomes with hirudin was similar among patients with and without diabetes, with a greater point estimate for the absolute difference in patients with diabetes.
Journal ArticleDOI

Genetic susceptibility to myocardial infarction and coronary artery disease

TL;DR: Four principal and interdependent processes--lipoprotein handling, endothelial integrity, arterial inflammation, arterIAL inflammation, and thrombosis--have been supported as important via the clustering of genes, thus far implicated in CAD susceptibility.
Journal ArticleDOI

Strategies to achieve coronary arterial plaque stabilization.

TL;DR: Evidence supporting plaque stabilization by Matrix metalloproteinase inhibitors as well as macrolide antibiotics and gene therapy approaches show promise in achieving plaque stabilization is discussed in detail in this review.
Journal ArticleDOI

A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction.

TL;DR: This tissue plasminogen activator preparation achieves a high rate of recanalization and, at the doses employed, exhibits increased fibrinogen sparing compared with intracoronary streptokinase.
Journal ArticleDOI

Whole-Genome Sequencing of a Healthy Aging Cohort

TL;DR: The results suggest healthy aging is an overlapping but distinct phenotype from exceptional longevity that may be enriched with disease-protective genetic factors, and suggests protection against cognitive decline is a genetic component of healthy aging.